The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 564.00
Bid: 560.00
Ask: 568.00
Change: 4.00 (0.71%)
Spread: 8.00 (1.429%)
Open: 560.00
High: 568.00
Low: 560.00
Prev. Close: 560.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

29 Jan 2009 16:04

RNS Number : 4846M
Gooch & Housego PLC
29 January 2009
 



For immediate release 

29 January 2009

Gooch & Housego PLC

(The "Company")

Trading Update

Gooch & Housego PLC, the specialist manufacturer of optical components and systems, today announces that it has experienced a sudden and significant drop in demand for certain of its products with the result that earnings for the year to 30 September 2009 are likely to be materially lower than the Board's original expectations for the current financial year. 

The most significant impact has been felt in the Company's key Acousto-Optics & Electro-Optics business unit where demand for acousto-optic Q-switches for general industrial, semiconductor and microelectronic applications has decreased by between a quarter and a half depending on the end user market. Whilst the order book remains strong, customers are significantly reducing their monthly requirements as they experience a similar reduction in demand for their laser systems. The effect is being felt on a global basis with the US, European and Asia-Pacific markets all affected. Indications are that demand will remain depressed for the foreseeable future.

Other sectors of the business, particularly those serving the aerospace, defence and life sciences markets have been less affected. The Company's Precision Optics, Fibre Optics and Instrumentation & Life Sciences business units are all trading broadly in line with the Board's original expectations for the current financial year.

In view of the decrease in sales steps are being taken to realign the cost base of the Company with the greatest savings taking place in the Acousto-Optics & Electro-Optics business unit.

The Company has been impacted by the recent rapid decline in the value of Sterling against the US Dollar and to a lesser extent the Euro. More than 85% of Company revenues are denominated in currencies other than Sterling with the US Dollar accounting for approximately 79% and the Euro approximately 6% with proportionately higher level of Company profits associated with the US Dollar.

The effect of the decline in the value of Sterling particularly against the US Dollar will to some extent offset the anticipated decrease in revenues at the Company's key Acousto-Optics & Electro-Optics business unit.

However, the Company's borrowings are predominantly denominated in US Dollars with approximately 85% of total borrowings in US Dollars and the balance in SterlingWhilst the US Dollar borrowings provide a natural hedge given the Company's significant US Dollar asset base and the high proportion of US Dollar revenues and profits, the fall in the value of Sterling against the US Dollar has the effect of increasing the magnitude of the Company's debt when translated into Sterling

Consequently, the Company is in discussions with its bankersThe Royal Bank of Scotland plcconcerning the impact of these currency issues that affect, and may continue to affect, certain bank covenant calculations. 

The Board is confident that the Company will meet its bank interest and debt repayment obligations to its bankers as they fall due. 

The Company believes that it is not appropriate to finalise its accounts for the year ended 30 September 2008 until the discussions with its bankers have been satisfactorily completed. Following completion of these discussions, the date of the Company's Annual General Meeting will be announced.

For further information, please contact:

Gareth Jones, Chief Executive Officer, 01460 256440

Peter J. Quinn, Chief Financial Officer, 01460 256446

Tim Thompson/Chris McMahon, Buchanan Communications Ltd, 020 7466 5000

Patrick Robb, Investec Bank (UK) Ltd, 020 7597 5169

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEDFMUSUSESF
Date   Source Headline
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards
21st Dec 202210:02 amRNSPosting of Annual Report and Notice of AGM
20th Dec 202212:30 pmRNSDirector/PDMR Shareholding
6th Dec 20224:26 pmRNSDirector/PDMR Shareholding
6th Dec 20229:38 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSResults for the year ended 30 September 2022
25th Nov 20223:17 pmRNSHolding(s) in Company
23rd Nov 20224:27 pmRNSHolding(s) in Company
18th Nov 20222:20 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSNotification of Full Year Results
27th Oct 202212:56 pmRNSHolding(s) in Company
18th Oct 20222:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.